BPH Global Registry (NCT05543200)
A Global Registry of Treatments and Outcomes for Benign Prostatic Hyperplasia
🩺 Plain-English Summary (8th-Grade Level)
Benign prostatic hyperplasia (BPH) is one of the most common performed surgical procedures in urology. Over the past few decades there have been an increasing development of newer surgical treatment options. Additionally, the outcome parameters for BPH treatments have been standardized. While data are available for the initial pivotal studies, post-market release data are lacking. Under the umbrella of uCARE, we have started a prospective, ongoing international registry for recording demographics and outcomes for patients undergoing surgical treatments for BPH.
Who can join: Review the eligibility criteria below.
Location: Keck Medicine of USC — Los Angeles, California
Age range: 18 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (30 Sites)
Showing the first 25 of 30 sites.
- Keck Medicine of USC — Los Angeles, California
- Toronto Western Hospital, University Health Network — Toronto, Ontario
- McGill University Health Centre — Montreal, Quebec
- University of Montreal Hospital Center — Montreal,
- Hospital Dr. Juan Morey La Unión — La Unión,
- Hospital del Trabajador — Santiago,
- The First Affiliated Hospital, Zhejiang University School of Medicine — Hangzhou,
- University of Cyprus — Nicosia,
- The Chinese University of Hong Kong — Hong Kong,
- Dr Baba Saheb Ambedkar Medical College and Hospital — Delhi,
- Shariati Hospital — Tehran,
- University of Basrah — Basra,
- Azienda Ospedaliero-Universitaria Careggi — Florence,
- Sapienza University of Rome, Division of Urology, Ospedale Sant'Andrea — Rome,
- Gracepark Medical Centre — Meru,
- Pandya Memorial Hospital — Mombasa,
- Kenyatta National Hospital — Nairobi,
- American University of Beirut — Beirut,
- Universiti Malaya — Kuala Lumpur,
- Kati University Hospital — Kati,
- Centro Medico Nacional Siglo XXI — Mexico City,
- Benue State University Teaching Hospital, Department of Surgery — Makurdi,
- Ahmadu Bello University Teaching Hospital — Zaria,
- Institute of Kidney Diseases Peshawar — Peshawar,
- Lady Reading Hospital — Peshawar,
📞 Contact the Study Coordinator
Phone: (323) 865-3700
Email: mihir.desai@med.usc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Benign Prostatic Hyperplasia
- PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs — La Mesa, California
- Comparing UroLift Experience Against Rezūm — Los Angeles, California
- Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath — Maywood, Illinois
- Optilume™ BPH Catheter System in Men With Symptomatic BPH — Little Rock, Arkansas
- Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate — Miami, Florida
- Laser Prostatectomy Database and Registry — Indianapolis, Indiana
Explore by condition: All Benign Prostatic Hyperplasia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.